Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 20

    1.

    Combination of a novel gene expression signature with a clinical nomogram improves the prediction of survival in high-risk bladder cancer.

    Riester M, Taylor JM, Feifer A, Koppie T, Rosenberg JE, Downey RJ, Bochner BH, Michor F.

    Clin Cancer Res. 2012 Mar 1;18(5):1323-33. Epub 2012 Jan 6.

    PMID:
    22228636
    [PubMed - in process]
    2.

    Comprehensive genome methylation analysis in bladder cancer: identification and validation of novel methylated genes and application of these as urinary tumor markers.

    Reinert T, Modin C, Castano FM, Lamy P, Wojdacz TK, Hansen LL, Wiuf C, Borre M, Dyrskjøt L, Orntoft TF.

    Clin Cancer Res. 2011 Sep 1;17(17):5582-92. Epub 2011 Jul 25.

    PMID:
    21788354
    [PubMed - indexed for MEDLINE]
    3.

    Urinary glycoprotein biomarker discovery for bladder cancer detection using LC/MS-MS and label-free quantification.

    Yang N, Feng S, Shedden K, Xie X, Liu Y, Rosser CJ, Lubman DM, Goodison S.

    Clin Cancer Res. 2011 May 15;17(10):3349-59. Epub 2011 Apr 1.

    PMID:
    21459797
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    4.

    Effects of mTOR inhibitor everolimus (RAD001) on bladder cancer cells.

    Chiong E, Lee IL, Dadbin A, Sabichi AL, Harris L, Urbauer D, McConkey DJ, Dickstein RJ, Cheng T, Grossman HB.

    Clin Cancer Res. 2011 May 1;17(9):2863-73. Epub 2011 Mar 17.

    PMID:
    21415218
    [PubMed - indexed for MEDLINE]
    Free Article
    5.

    New strategies in muscle-invasive bladder cancer: on the road to personalized medicine.

    Shah JB, McConkey DJ, Dinney CP.

    Clin Cancer Res. 2011 May 1;17(9):2608-12. Epub 2011 Mar 17. Review.

    PMID:
    21415213
    [PubMed - indexed for MEDLINE]
    Free Article
    6.

    In vivo evaluation of mucoadhesive nanoparticulate docetaxel for intravesical treatment of non-muscle-invasive bladder cancer.

    Mugabe C, Matsui Y, So AI, Gleave ME, Baker JH, Minchinton AI, Manisali I, Liggins R, Brooks DE, Burt HM.

    Clin Cancer Res. 2011 May 1;17(9):2788-98. Epub 2011 Feb 28.

    PMID:
    21357680
    [PubMed - indexed for MEDLINE]
    Free Article
    7.

    Excision repair cross-complementing group 1 may predict the efficacy of chemoradiation therapy for muscle-invasive bladder cancer.

    Kawashima A, Nakayama M, Kakuta Y, Abe T, Hatano K, Mukai M, Nagahara A, Nakai Y, Oka D, Takayama H, Yoshioka T, Hoshida Y, Itatani H, Nishimura K, Nonomura N.

    Clin Cancer Res. 2011 Apr 15;17(8):2561-9. Epub 2010 Dec 21.

    PMID:
    21177407
    [PubMed - indexed for MEDLINE]
    Free Article
    8.

    Hypermethylation of CpG islands and shores around specific microRNAs and mirtrons is associated with the phenotype and presence of bladder cancer.

    Dudziec E, Miah S, Choudhry HM, Owen HC, Blizard S, Glover M, Hamdy FC, Catto JW.

    Clin Cancer Res. 2011 Mar 15;17(6):1287-96. Epub 2010 Dec 7.

    PMID:
    21138856
    [PubMed - indexed for MEDLINE]
    Free Article
    9.

    Foxo3a suppression of urothelial cancer invasiveness through Twist1, Y-box-binding protein 1, and E-cadherin regulation.

    Shiota M, Song Y, Yokomizo A, Kiyoshima K, Tada Y, Uchino H, Uchiumi T, Inokuchi J, Oda Y, Kuroiwa K, Tatsugami K, Naito S.

    Clin Cancer Res. 2010 Dec 1;16(23):5654-63.

    PMID:
    21138866
    [PubMed - indexed for MEDLINE]
    Free Article
    10.

    Three epigenetic biomarkers, GDF15, TMEFF2, and VIM, accurately predict bladder cancer from DNA-based analyses of urine samples.

    Costa VL, Henrique R, Danielsen SA, Duarte-Pereira S, Eknaes M, Skotheim RI, Rodrigues A, Magalhães JS, Oliveira J, Lothe RA, Teixeira MR, Jerónimo C, Lind GE.

    Clin Cancer Res. 2010 Dec 1;16(23):5842-51. Epub 2010 Oct 25.

    PMID:
    20975101
    [PubMed - indexed for MEDLINE]
    Free Article
    11.

    Glycogen synthase kinase-3beta: a prognostic marker and a potential therapeutic target in human bladder cancer.

    Naito S, Bilim V, Yuuki K, Ugolkov A, Motoyama T, Nagaoka A, Kato T, Tomita Y.

    Clin Cancer Res. 2010 Nov 1;16(21):5124-32. Epub 2010 Oct 1.

    PMID:
    20889919
    [PubMed - indexed for MEDLINE]
    Free Article
    12.

    The effectiveness of off-protocol adjuvant chemotherapy for patients with urothelial carcinoma of the urinary bladder.

    Svatek RS, Shariat SF, Lasky RE, Skinner EC, Novara G, Lerner SP, Fradet Y, Bastian PJ, Kassouf W, Karakiewicz PI, Fritsche HM, Müller SC, Izawa JI, Ficarra V, Sagalowsky AI, Schoenberg MP, Siefker-Radtke AO, Millikan RE, Dinney CP.

    Clin Cancer Res. 2010 Sep 1;16(17):4461-7. Epub 2010 Jul 22.

    PMID:
    20651056
    [PubMed - indexed for MEDLINE]
    Free Article
    13.

    Prediction of stage, grade, and survival in bladder cancer using genome-wide expression data: a validation study.

    Lauss M, Ringnér M, Höglund M.

    Clin Cancer Res. 2010 Sep 1;16(17):4421-33. Epub 2010 Aug 24.

    PMID:
    20736328
    [PubMed - indexed for MEDLINE]
    Free Article
    14.

    Prostate stem cell antigen: a Jekyll and Hyde molecule?

    Saeki N, Gu J, Yoshida T, Wu X.

    Clin Cancer Res. 2010 Jul 15;16(14):3533-8. Epub 2010 May 25. Review.

    PMID:
    20501618
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    15.

    AdCD40L immunogene therapy for bladder carcinoma--the first phase I/IIa trial.

    Malmström PU, Loskog AS, Lindqvist CA, Mangsbo SM, Fransson M, Wanders A, Gårdmark T, Tötterman TH.

    Clin Cancer Res. 2010 Jun 15;16(12):3279-87. Epub 2010 May 4.

    PMID:
    20448220
    [PubMed - indexed for MEDLINE]
    Free Article
    16.

    Preoperative CTLA-4 blockade: tolerability and immune monitoring in the setting of a presurgical clinical trial.

    Carthon BC, Wolchok JD, Yuan J, Kamat A, Ng Tang DS, Sun J, Ku G, Troncoso P, Logothetis CJ, Allison JP, Sharma P.

    Clin Cancer Res. 2010 May 15;16(10):2861-71. Epub 2010 May 11.

    PMID:
    20460488
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    17.

    Gene expression signature in urine for diagnosing and assessing aggressiveness of bladder urothelial carcinoma.

    Mengual L, Burset M, Ribal MJ, Ars E, Marín-Aguilera M, Fernández M, Ingelmo-Torres M, Villavicencio H, Alcaraz A.

    Clin Cancer Res. 2010 May 1;16(9):2624-33. Epub 2010 Apr 20.

    PMID:
    20406841
    [PubMed - indexed for MEDLINE]
    Free Article
    18.

    Fibroblast growth factor receptor 3 mutation analysis on voided urine for surveillance of patients with low-grade non-muscle-invasive bladder cancer.

    Zuiverloon TC, van der Aa MN, van der Kwast TH, Steyerberg EW, Lingsma HF, Bangma CH, Zwarthoff EC.

    Clin Cancer Res. 2010 Jun 1;16(11):3011-8. Epub 2010 Apr 19.

    PMID:
    20404005
    [PubMed - indexed for MEDLINE]
    Free Article
    19.

    Gene signatures for the prediction of response to Bacillus Calmette-Guerin immunotherapy in primary pT1 bladder cancers.

    Kim YJ, Ha YS, Kim SK, Yoon HY, Lym MS, Kim MJ, Moon SK, Choi YH, Kim WJ.

    Clin Cancer Res. 2010 Apr 1;16(7):2131-7. Epub 2010 Mar 16.

    PMID:
    20233890
    [PubMed - indexed for MEDLINE]
    Free Article
    20.

    Implications of LINE1 methylation for bladder cancer risk in women.

    Wilhelm CS, Kelsey KT, Butler R, Plaza S, Gagne L, Zens MS, Andrew AS, Morris S, Nelson HH, Schned AR, Karagas MR, Marsit CJ.

    Clin Cancer Res. 2010 Mar 1;16(5):1682-9. Epub 2010 Feb 23.

    PMID:
    20179218
    [PubMed - indexed for MEDLINE]
    Free PMC Article

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk